Breakthrough

Lactoferrin: The Iron Supplement Alternative

Updated Apr 26, 2026 · 7 min read
Sensitive populations: This article references pregnancy or pediatric. Always confirm any supplement change with your obstetrician or midwife before starting — dosing, contraindications, and risk profile shift in these groups.

Iron deficiency is the most common nutrient deficiency in the world, affecting an estimated 2 billion people. The standard treatment is ferrous sulfate. It works, but the side effects — constipation, nausea, abdominal cramps, dark stools, and a metallic taste — cause many patients to stop before their anemia is corrected. Lactoferrin is a different option. It is an iron-binding protein naturally found in breast milk, tears, and saliva. In trials, bovine (cow) lactoferrin can improve iron status with much fewer gut symptoms and at a much smaller actual iron dose.

How lactoferrin works

Lactoferrin does not flood the body with iron the way ferrous sulfate does. Instead, it shifts how the body handles the iron it already has. It binds iron tightly, helps regulate hepcidin (the hormone that controls iron release from stores), and modulates inflammation. Chronic inflammation drives hepcidin up, locks iron away from red-blood-cell production, and causes the “anemia of inflammation” that often does not improve with standard iron pills. By calming this signal, lactoferrin can free up iron the body already has.

Clinical trial evidence

The most cited evidence comes from a series of Italian trials in pregnant women with iron-deficiency anemia. Paesano et al. 2010 (International Journal of Immunopathology and Pharmacology, PMID 20525393) compared 100 mg/day of bovine lactoferrin to ferrous sulfate (about 100–105 mg of elemental iron daily). Lactoferrin produced equal or greater rises in hemoglobin and serum ferritin, with much less GI distress. Because bovine lactoferrin contains only a small amount of bound iron (roughly 1–2 mg per 100 mg of protein), patients took a small fraction of the elemental iron used in the comparator group. A 2023 meta-analysis by Lepanto et al. (Frontiers in Pharmacology) pooled multiple RCTs and confirmed significant improvements in hemoglobin, ferritin, and serum iron with bovine lactoferrin and consistently fewer adverse events than standard iron salts. Effects in non-pregnant adults and children are smaller and more variable, so the data is strongest in pregnancy.

Advantages over standard iron

The biggest practical advantage is tolerability. Iron therapy fails most often because patients stop taking it. Lactoferrin also avoids some of the gut-side effects linked to high-dose ferrous iron, including oxidative stress on intestinal cells and shifts in the gut microbiome. Because it has antimicrobial properties, it may be especially useful where iron deficiency overlaps with gut infections.

Who should consider it

Lactoferrin is most compelling for pregnant women (high iron needs and poor tolerance of standard iron), patients who stopped ferrous sulfate because of side effects, and people with chronic inflammatory conditions where hepcidin is elevated. It is more expensive than ferrous sulfate ($20–$40 per month versus a few dollars), but the math changes if it lets a patient stay on therapy long enough to actually correct the anemia. Typical doses in trials are 100–300 mg of bovine lactoferrin per day, taken on an empty stomach. Lactoferrin is dairy-derived and is not appropriate for people with severe dairy-protein allergy. Anyone treating significant anemia should still work with a clinician to confirm the diagnosis, identify the cause, and recheck blood work.

Sources

  1. Paesano R, et al. “Lactoferrin efficacy versus ferrous sulfate in curing iron disorders in pregnant and non-pregnant women.” International Journal of Immunopathology and Pharmacology, 2010. PMID 20525393.
  2. Lepanto MS, et al. “Bovine lactoferrin: an effective treatment for iron deficiency anemia — a systematic review and meta-analysis.” Frontiers in Pharmacology, 2023.
  3. Yen CC, et al. “The expected benefits of lactoferrin on immunity: a meta-analysis of randomized controlled trials.” European Journal of Clinical Nutrition, 2021.
  4. Ochoa TJ, Cleary TG. “Effect of lactoferrin on enteric pathogens.” Biochimie, 2009. PMID 18809460.